-+ 0.00%
-+ 0.00%
-+ 0.00%

ALDEYRA THERAPEUTICS INC - PHASE 2/3 TRIAL OF ADX-2191 EXPECTED IN 2025

Reuters·07/24/2025 11:00:00

Please log in to view news